menu
Clinical Decision Support Systems Market Key Developments Trends, Analysis and Forecasts to 2027
Clinical Decision Support Systems Market Key Developments Trends, Analysis and Forecasts to 2027
The global clinical decision support systems (CDSS) market, during the forecast period 2018 to 2023, will register growth at a CAGR of 12%.

Overview

The global clinical decision support systems (CDSS) market, during the forecast period 2018 to 2023, will register growth at a CAGR of 12%. The market for clinical decision support systems (CDSS) is set to reach US$1.76 billion by 2023. As per market analysts, the global market is anticipated to witness growth owing to the factors such as increasing geriatric population as well as increasing number of hospitals. However, the market will face challenges and restraints due to risk of data privacy and the upload of data leading to vulnerabilities during the forecast period 2018 to 2023.

Growing demand for data-driven technologies in the market is set to play a key role in determining the growth potential during 2018 to 2023 years. Analysts have also studied the market to understand potential threats and challenges the market companies could face. Although the market is poised to grow at a fast pace across component, product, model, delivery mode, type, mode of advice, application segments, factors such as vulnerabilities from hackers could slow down the market's growth worldwide.

Competitive Landscape

Clinical decision support systems (CDSS) have seen increased demand over the years, due to the advent of electronic health records and integration of the clinical decision support system. Companies functioning in the global market are also being challenged due to the cash strapped reality of healthcare providers and budget concerns. Mergers and acquisitions by clinical decision support systems (CDSS) market companies are anticipated to help the market during the forecast period 2018 to 2023. As the market is set to register a high CAGR of 12% and is also anticipated to reach a US$1.76 billion by 2023, the report highlights key areas companies need to focus on. The report suggests that the market will see a healthy growth in the long run till 2023. Based on SWOT analysis and market’s analysis based on Porters’ Five Force Model presented in the market report. Mergers and acquisitions by market companies are anticipated to help the market during the forecast period 2022 to 2027.

Market Segmentation

The Clinical Decision Support Systems Market Share has been segmented into component, product, model, delivery mode, type, mode of advice, application. Based on the segment which is component, the market is categorized on the basis of software, services, hardware. The global market for clinical decision support systems (CDSS) is further segmented based on product into integrated CDSS, standalone CDSS. Furthermore, the market, on the basis of model is segmented into knowledge-based CDSS, non-knowledge-based CDSS. Based on the segment which is delivery mode, the market is categorized on the basis of on-premise CDSS, cloud-based CDSS. The global market for clinical decision support systems (CDSS) is further segmented based on type into active CDSS, passive CDSS. Furthermore, the market, on the basis of mode of advice is segmented into inpatient settings, ambulatory care settings. Based on the segment which is setting, the market is categorized on the basis of therapeutic clinical decision support systems, diagnostic clinical decision support systems.

The global computerised decision support system (CDSS) market research report covers all the aspects of the based on the segmental analysis of these component, product, model, delivery mode, type, mode of advice, application segments. Analysts have also studied the global market's regional markets spread across many continents and countries. The component, product, model, delivery mode, type, mode of advice, application segments along with their sub-segments have been analyzed and companies functioning in the market across these segments are profiled and analyzed based on input and feedback from market-based decision makers as well as primary and secondary sources. The market research report presents analysis-based information for companies functioning in the market.

Regional Overview

Concerns regarding the protection of sensitive health-related data may hinder the market growth. The market research report suggests that companies in the market could be supported by creasing number of emergency department (ED) visits as well as the spike in emergency visits during the forecast period. The market is set to register growth at a high CAGR owing to these key factors. The market is spread across North America, Europe, Asia-Pacific, and other parts of the world. The global clinical decision support systems (CDSS) market research report reveals that APAC, North America, and Europe regional markets will dominate the global market for clinical decision support systems (CDSS) during the forecast period 2018 to 2023. As per market analysts, the market is set to witness tremendous growth across inpatient settings and ambulatory care segments in North America which covers markets across the United States, Canada, Mexico and several other regional markets. Companies active in the market are also analyzed and studied in the market research report.

The market for Europe covers smaller market segments of Germany, Italy, France, and the United Kingdom. Additionally, market research report covers the Asia-Pacific region covering markets from India, China, Japan, Australia, and others. The market is also spread across the rest of the world. The market report covers all such regions including the Middle East, Africa, Brazil, and others.

Industry News

Premier Inc., a major healthcare improvement firm, has agreed to buy Stanson Health, a SaaS-based supplier of clinical decision support (CDS) solutions that are built directly into the EHR workflow, delivering real-time, patient-specific best practises at the point of treatment. Stanson is also working on a prior authorization product that, once completed, will allow for near-real-time prior authorization decisions for medical and pharmaceutical benefits. Which is intended to save time and money for patients and payers while also improving patient and provider satisfaction.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013,

United States of America